|
env
|
gag
|
pol
|
---|
 |
Distance
|
Sample size
|
p-value
b
|
Distance
|
Sample size
|
p-value
b
|
Distance
|
Sample size
|
p-value
b
|
---|
Patients c | 5.23 ± 0.85 | n = 4 | 1.19 × 10-11 | 2.39 ± 0.60 | n = 4 | 6.37 × 10-13 | 1.54 ± 0.22 | n = 4 | 5.12 × 10-14 |
Controls | 11.02 ± 0.92 | n = 23 | - | 6.27 ± 0.66 | n = 32 | - | 2.95 ± 0.18 | n = 25 | - |
Between-group | 14.21 ± 1.48 | - | - | 8.23 ± 1.15 | - | - | 4.12 ± 0.37 | - | - |
- a Within-group mean nucleotide distances measured as substitutions per 100 sites with estimated 95% standard of error between selected HIV-1 gene sequences. Between-group mean nucleotide distances measured as substitutions per 100 sites with estimated 95% standard error comparing selected HIV-1 gene sequences from the four patients to equivalent sequences from local controls. The control group is randomly selected non-clustered CRF01_AE sequences.
- b Unpaired t-test p-value calculated with respect to controls.
- c Evolutionary distances of all genes are significantly different from the corresponding gene among control sequences (p = 1.19 × 10-11, p = 6.37 × 10-13 and p = 5.12 × 10-14 respectively).